C4 Therapeutics, Inc. (CCCC)

C4 Therapeutics Revenue

C4 Therapeutics had revenue of $15.36M in the quarter ending September 30, 2024, with 38.75% growth. This brings the company's revenue in the last twelve months to $33.67M, up 65.45% year-over-year. In the year 2023, C4 Therapeutics had annual revenue of $20.76M, down -33.25%.

• Revenue (ttm): $33.67M
• Revenue Growth: +65.45%
• P/S Ratio: 7.76
• Revenue / Employee: $232,193
• Employees: 145
• Market Cap: 286.59M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	20.76M	-10.34M	-33.25%
Dec 31, 2022	31.10M	-14.69M	-32.08%
Dec 31, 2021	45.79M	12.59M	37.93%
Dec 31, 2020	33.20M	11.81M	55.25%
Dec 31, 2019	21.38M	2.02M	10.42%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.